JP3479654B2 - “Shingu Fusaimaru”-Emergency middle-aged medicine (Chinese medicine) for treating cerebrovascular disease (CVD) - Google Patents

“Shingu Fusaimaru”-Emergency middle-aged medicine (Chinese medicine) for treating cerebrovascular disease (CVD)

Info

Publication number
JP3479654B2
JP3479654B2 JP2001235565A JP2001235565A JP3479654B2 JP 3479654 B2 JP3479654 B2 JP 3479654B2 JP 2001235565 A JP2001235565 A JP 2001235565A JP 2001235565 A JP2001235565 A JP 2001235565A JP 3479654 B2 JP3479654 B2 JP 3479654B2
Authority
JP
Japan
Prior art keywords
minutes
cerebrovascular disease
medicine
cerebral
cvd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2001235565A
Other languages
Japanese (ja)
Other versions
JP2003034646A (en
Inventor
文徳 劉
輝彦 下田
雲明 趙
紫丹 劉
紫▲チュン▼ 劉
Original Assignee
輝彦 下田
文徳 劉
雲明 趙
紫丹 劉
紫▲チュン▼ 劉
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 輝彦 下田, 文徳 劉, 雲明 趙, 紫丹 劉, 紫▲チュン▼ 劉 filed Critical 輝彦 下田
Priority to JP2001235565A priority Critical patent/JP3479654B2/en
Publication of JP2003034646A publication Critical patent/JP2003034646A/en
Application granted granted Critical
Publication of JP3479654B2 publication Critical patent/JP3479654B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は脳血管の病気(CV
D)を治療する毒、副作用のない救急中成薬である。具
体的には有名な漢方薬を有効成分として作られた救急中
成薬である。当薬は脳血栓(cerebral inf
arction)、脳血栓形成(cerebral t
hrombosis)、脳栓塞(cerebral e
mbolism)、脳出血(cerebral hem
orrhage)、蛛网膜下腔出血(subarach
noid hemorrhage)などの病気の救急治
療及び予防に効果がある。
TECHNICAL FIELD The present invention relates to cerebrovascular disease (CV).
It is an emergency medicine for treating D) with no poison or side effects. Specifically, it is a first aid medicine made from famous Chinese herbs. The drug is cerebral inf
arcion, cerebral thrombus formation (cerebral t)
hombosis), cerebral embolism (cerebral e)
mbolism), cerebral hemorrhage
orrhage), subarachnoid hemorrhage (subarach)
It is effective for emergency treatment and prevention of diseases such as noid hemorrhage.

【0002】[0002]

【従来の技術】現在、国内や外国の西洋医学では脳血管
の病気(CVD)を治療するのに、以下の方法を採用し
ている。 1、脱水剤(dehydrant)と類固醇薬物(st
eroid)治療法、脳水腫(cerebral ed
ema)及び微循環障害(microcirculat
ory disturbance)を改善する。しか
し、このような薬物を使用すると正常な脳部分が脱水の
症状を起こし、血脳障害(bbb)により破壊された脳
血栓の部分の脳水腫が深刻になってしまう。そして、こ
のような薬物は心血輸出量を増加させるため、顱内圧
(intracranial pressure)の高
い患者及び心力衰竭(cardiac failur
c)の患者は使用禁止。血管拡張剤(vasodila
tor)の使用は顱内圧(intracranial
pressure)を高め、出血性脳血栓患者の出血の
部分を拡大してしまう。肝、腎機能の不良或いは低血圧
者には使用しないほうがいい。 2、抗血栓療法、一般的には抗凝剤(decoagul
ant)を使用する。この治療法に関しては、いまだに
医学界では議論があり、そして、出血症状のある患者、
潰瘍(cankcr)の病歴がある人、厳重高血圧病
(hypertension)及び肝、腎の病気のある
患者は使用禁止。 3、抗繊溶薬物(6−安基己酸〈6−aminohex
anolic〉と止血環酸〈tranexamicac
id〉)の使用。最新の観点では正規に使用すると再出
血の発生率を減らすことができない。脳血管の病気(C
VD)の患者には出血の症状があるか、血栓形成の症状
があるので、脱水剤(dehydrant)或いは類固
醇薬物(steroid)、止血薬物(hemosta
t)、凝血薬物(coagulant)などの使用は特
殊有効な救急治療法ではない。その上、単一で毒、副作
用のある部分の治療方法である。その他の治療方法:応
用脳代謝活化剤(activator)、脳保護剤(p
rotective)、高圧羊艙療法(hyperba
ric oxygen chamber therap
y)。これらの治療方法はあまり効果なく、補助治療法
として使われている。手術治療法は難度が高いうえ、発
病部の厳重度合にも制限される。中国の医学における脳
血管の病気(CVD)の救急治療では、“清火去痰、 合、全面的に達した治療の中成薬はない。したがって、
脳血管の病気(CVD)の治療においては特別で理想な
治療薬さえないのだから、まして救急治療の中成薬。
2. Description of the Related Art At present, the following methods are used in Western medicine in Japan and abroad to treat cerebrovascular disease (CVD). 1. Dehydrant and solid drug (st
eroid treatment, cerebral edema
em) and microcirculatory disorders (microcirculatory)
ory disturbance) is improved. However, when such a drug is used, the normal brain part causes dehydration, and cerebral edema of the part of the cerebral thrombus destroyed by the blood-brain disorder (bbb) becomes serious. In addition, since such drugs increase cardiac blood export, patients with high intracranial pressure and cardiac failure.
Do not use for patients in c). Vasodilator (vasodila)
tor is used for intracranial pressure.
It increases the pressure and enlarges the bleeding area in patients with hemorrhagic cerebral thrombosis. It should not be used for people with poor liver or renal function or low blood pressure. 2. Antithrombotic therapy, generally anticoagulant
ant) is used. There is still debate in the medical community about this treatment, and patients with bleeding symptoms,
Do not use if you have a history of ulcer (cankcr), severe hypertension, or patients with liver or kidney disease. 3, anti-fibrinolytic drug (6-amino group acid <6-aminohex
anolic> and hemostatic acid <tranexamicac>
use of id>). From a modern perspective, regular use cannot reduce the incidence of rebleeding. Cerebrovascular disease (C
VD patients have bleeding symptoms or thrombus formation symptoms. Therefore, dehydration agents, steroids, and hemostatic agents (hemosta).
t), the use of coagulants, etc. is not a particularly effective emergency treatment. Moreover, it is a single treatment method for poisonous and side effects. Other treatment methods: applied brain metabolism activator (activator), brain protectant (p
Protective, high-pressure sheep fleece therapy (hyperba)
ric oxygen chamber therap
y). These treatments are not very effective and are used as adjunctive treatments. Surgical treatment methods are difficult and are also limited by the severity of the affected area. In the emergency treatment of cerebrovascular disease (CVD) in Chinese medicine, "Kiyomi expectorant, If there is no complete cure, there is no cure. Therefore,
There is no special and ideal remedy for the treatment of cerebrovascular disease (CVD), so it is a neat emergency medicine.

【0003】[0003]

【発明が解決しようとする課題】毒、副作用のない脳血
管の病気(CVD)を救急治療する有効な中成薬を開発
することは現代医学界の最も重要な研究課題である。そ
して、本発明の薬はこの課題を解決する唯一の鍵となる
薬物である。迅速で有効に脳血管の病気(CVD)を救
急治療する毒、副作用のない純漢方薬製剤を提供するこ
とは本発明の目的である。
The development of effective medicinal drugs for the emergency treatment of cerebrovascular disease (CVD) without toxicity and side effects is the most important research topic in the modern medical community. And the drug of the present invention is the only key drug to solve this problem. It is an object of the present invention to provide a pure Chinese herbal medicine preparation that is free of poison and side effects for rapid and effective emergency treatment of cerebrovascular disease (CVD).

【0004】[0004]

【課題を解決するための手段】脳血管病気(CVD)の
発病部は脳にある。中国医学の臓腑弁証学の理論による
と,心、肝、腎の三つの陰陽失調,そして憂、思、悩、
怒或いは過労 実下虚、陰陽不相維系の危急症候を形成する。口眼歪
斜、語言不利、偏身麻木或いは突然昏仆(突然気絶す
る)、不省人事(気を失うまま起きない)、半身不随は
病気の特徴である。発病の特徴は、起病急驟(急に病気
にかかる)、変化迅速、見症多端(症状は様々)、即危
[Means for Solving the Problems] The onset part of cerebrovascular disease (CVD) is in the brain. According to the theory of visceral dialectics in Chinese medicine, there are three types of yin-yang disorder of the heart, liver and kidney, and anxiety, thought, worries,
Anger or overwork It forms a symptom of the illness and the Yin and Yang disordered system. Oral distortion, unfavorable language, unbalanced hemp tree or sudden stupor (sudden faint), poor HR (never wake up), hemiplegia are characteristic of illness. The characteristics of the onset of illness are rapid onset of illness (sudden illness), rapid change, multiple illnesses (various symptoms), immediate danger.

【0005】[0005]

【発明の実施の形態】以下は薬剤の成分(重量分) 処方箋の中:牛黄(bezoar)、麝香(mus
k)、氷片(boneol)、羚羊角(cornusa
tgae)は開 醒神、清心豁痰、涼肝息風、定驚除邪
気,通経絡、透肌骨、 血”を原因とした“中風(脳卒中)”の諸症状を取り除
くことができる。本発明の薬―――神英普済丸は以上の
処方でできている。重量比に従って原料を選び、常規製
剤工芸で臨床に適用する丸剤を作る。上の処方箋の中の
どの薬も優良なものを選ぶ。本発明の薬―――神英普済
丸の薬剤は丸剤であり、その製法は:処方箋に記載する
原料となる薬を重量比に従って優良なもの選び、粉粉に
してから篩にかけて、丸剤を作る。珠砂為衣、一粒の重
さは3グラム。本発明の薬―――神英普済丸は脳血管病
気(CVD)を救急治療する効力があり,脳血栓(ce
rebral infarction)、脳栓塞(ce
rebral embolism)、脳出血(cere
bral hemorrhage)の急性期救急には良
好な治療効果がある。
BEST MODE FOR CARRYING OUT THE INVENTION The following are components (parts by weight) of drugs. In the prescription: bezoar, musk
k), ice flakes (boneol), goose horns (cornusa)
tgae) is an awakening god, Kishinshin's phlegm, cool-lived breath, constant euphoria, meridian, transparent skin, It can eliminate various symptoms of "middle wind (stroke)" caused by "blood." The drug of the present invention --- Shinei Fusai Maru is made according to the above prescription. Make pills for clinical application by formulation crafts.Select any excellent drug from the above prescriptions.The drug of the present invention --- Shinei Fusai Maru's drug is a pill, and its manufacturing method is : Select the excellent raw material medicines listed in the prescription according to the weight ratio, make powder and sieve to make pills.Pear sand gauze, the weight of one grain is 3g. --Shin-Ei Fusai Maru has the effect of emergency treatment for cerebrovascular disease (CVD),
rebar infarction, cerebral embolism (ce)
rebral embolism), cerebral hemorrhage
There is a good therapeutic effect in the acute emergency of bral hemorrhage.

【0006】[0006]

【実施例】当発明の発明者――劉 文徳(主任医師)は
医者を勤めて四十年“神英普済丸”を使って様々な脳血
管病気(CVD)の難病を治してきた。以下はその典型
的な病例の一部である。 典型病例: [病例一]氏名:張振生、男、56歳、公務員。199
4年12月31日午後4時、突然目眩し、四肢無力を感
じ、右側の体が動くことができなくなり、口が歪み、話
せなくなり、大小便失禁。即座に遼寧省阜新市第二医院
に入院。“CT”検査の結果“全脳2/3大面積脳栓
塞”と判断され、“脳血栓”の西洋薬で治療するより仕
方がなく、死に至る状態だと告げられました。その患者
には高血圧、高脂血症、動脈硬化症の病歴がある。患者
は午後8時に、当発明――“神英普済丸”を4時間ごと
に一粒服用し、翌朝8時頃、歪んでた口が正常に戻り、
はっきり話せるようになり、四肢にも知覚が戻り、右半
身も軽い運動ができるようになり、大小便の失禁も治っ
た。 [病例二] 氏名:劉剣霞、女、62歳、定年者。糖尿病の患者で、
1999年5月に右半身に力なく、普通に歩けなくな
り、病院で検査した結果“脳血栓”である。“脳血栓”
を治療する各種西洋薬や北京同仁堂の“牛黄安宮丸”四
粒を使ってもまったく効力がない。そのあと、当発明―
―“神英普済丸”を二粒服用し、翌日に症状が消え、自
由に歩けるようになった。“多くの‘牛黄安宮丸’を使
用しても一粒の‘神英普済丸’の効力に及ばない”と患
者が言っていた。 [病例二] 氏名:張桂蘭、女、76歳、家事手伝い。1996年3
月18日の夜、突然頭痛を感じ、口が歪み、肢体が動け
なくなった。入院して“脳溢血”と診断された。顱内圧
(intracranial pressure)を下
げる薬物や止血薬物を使用するほかに、当発明の薬物―
―神英普済丸二粒を使用した。六時間後に症状はすっか
り消え、口の歪みも治り、言語の能力も戻り、支えると
歩くこともできる。
EXAMPLES Inventor of the present invention: Liu Wende (chief doctor) worked as a doctor for 40 years to cure various intractable diseases of cerebrovascular disease (CVD) using "Shin-Ei Fusai Maru". The following are some of the typical cases. Typical illness example: [Illustrative case 1] Name: Zhang Zhensei, male, 56 years old, public employee 199
At 4 pm on December 31, 4th, suddenly dizziness, powerlessness in the extremities, inability to move the right side of the body, distorted mouth, inability to speak, incontinence of urine and urine. Immediately admitted to Fuxin City Second Clinic, Liaoning Province. As a result of "CT" examination, it was judged as "whole brain ⅔ large area cerebral embolism", and he was told that he was in a state of death and there was no choice but to treat it with Western medicine for "cerebral thrombosis". The patient has a history of hypertension, hyperlipidemia, and arteriosclerosis. At 8:00 pm, the patient took the present invention- “Shinei Fusai Maru” every 4 hours, and at around 8:00 the next morning, the distorted mouth returned to normal,
I became able to speak clearly, my senses returned to my extremities, my right half of the body was able to do light exercise, and incontinence of urine and urine was cured. [Case example 2] Name: Liu Kenxiang, woman, 62 years old, retired. In a diabetic patient,
In May 1999, he was unable to walk normally due to lack of strength in his right half of the body, and as a result of a hospital inspection, he had a "cerebral blood clot". "Brain thrombosis"
Even if you use various Western medicines to treat the disease and four "Uhuang Angu Maru" tablets from Beijing Dojindo, they have no effect. After that, the present invention-
-I took two tablets of Shinei Fusai Maru and the symptoms disappeared the next day, and I was able to walk freely. The patient said, "Even if many" Ushio Angu Maru "is used, it does not reach the effect of one" Shinei Fusai Maru ". [Case 2] Name: Zhang Guilin, woman, 76 years old, helping with housework. 1996 March
On the night of the 18th of March, I suddenly felt a headache, my mouth was distorted, and my limbs became immobile. He was admitted to the hospital and was diagnosed with "cerebral hemorrhage". In addition to using a drug that reduces intracranial pressure and a hemostatic drug, the drug of the present invention-
-I used two Shinei Fuze Maru grains. Six hours later, the symptoms disappeared completely, the distortion of the mouth was healed, the ability to speak was restored, and the person could walk with support.

【0007】[0007]

【発明の効果】神英普済丸は:脳血栓形成(cereb
ral thrombosis)、脳栓塞(cereb
ral embolism)、脳出血(cerebra
l hemorrhage)、蛛网膜下腔出血(sub
arachnoid hemorrhage)などの脳
血管病気(CVD)を治療する効力がある。当発明薬物
――神英普済丸は脳血管病気(CVD)を治療する救急
漢方薬であり、著しい効力を持っている。現代社会では
数多くの人々が脳血管病気(CVD)で命を失ってい
る。神英普済丸を世に送り出せば、多くの人の命が助け
られる上、脳血管病気(CVD)による後遺症を減らし
たり無くしたりすることにも効果がある。
EFFECTS OF THE INVENTION Shinei Fusai Maru: Cerebral thrombus formation
ral thrombosis, cereb
ral embolism), cerebral hemorrhage (cerebra)
hemorrhage), subretinal hemorrhage (sub)
Efficacy to treat cerebrovascular diseases (CVD) such as arachnoid hemorrhage. The drug of the present invention, Shinei Fusai Maru, is an emergency herbal medicine for treating cerebrovascular disease (CVD) and has remarkable efficacy. Many people in modern society die of cerebrovascular disease (CVD). Sending Shin-Ei Fusai Maru to the world will help save the lives of many people, and will also be effective in reducing or eliminating the aftereffects of cerebrovascular disease (CVD).

フロントページの続き (73)特許権者 501307103 劉 紫丹 中国広東省深▲セン▼市福田区上梅林奥 士達宿舎802室 (73)特許権者 501307114 劉 紫▲チュン▼ 中国広東省深▲セン▼市福田区上梅林奥 士達宿舎802室 (72)発明者 劉 文徳 中国広東省深▲セン▼市福田区上梅林奥 士達宿舎802室 (72)発明者 下田 輝彦 茨城県土浦市神立中央4−1−4−31 (72)発明者 趙 雲明 茨城県土浦市神立中央4−1−4−31 (72)発明者 劉 紫丹 中国広東省深▲セン▼市福田区上梅林奥 士達宿舎802室 (72)発明者 劉 紫▲チュン▼ 中国広東省深▲セン▼市福田区上梅林奥 士達宿舎802室 (58)調査した分野(Int.Cl.7,DB名) A61K 35/78 A61K 9/20 A61K 35/12 Front page continuation (73) Patent holder 501307103 Liu Sitan Shenzhen, Guangdong Province, China ▲ Sen ▼ Fukuda-ku Kamumebayashi Okada Dormitory 802 room (73) Patent holder 501307114 Liu Zi Chun ▼ Shenzhen, Guangdong Province, China ▼ Kamimeirin Okuda Dormitory 802, Fukuda-ku, City (72) Inventor, Liu Wende, Shenzhen, Guangdong Province, China ▲ Sen ▼ Kamimeirin Oku Datu Dormitory, Fukuda-ku, City 802 (72) Inventor Teruhiko Shimoda Tsuchiura City Ibaraki Prefectural Central 4-1-4-31 (72) Inventor Zhao Yunmei 4-1-4-31 Jinchuo, Tsuchiura City, Ibaraki Prefecture 4-1-4-31 (72) Inventor Liu Sitan Shenzhen, Guangdong Province, China 802 rooms for dormitories (72) Inventor Liu Zi ▲ Chun ▼ Shenzhen, Guangdong Province, China ▼ Kamimeilin Okushi, Fukuda-ku, City 802 rooms for dormitories (58) Fields investigated (Int.Cl. 7 , DB name) A61K 35 / 78 A61K 9/20 A61K 35/12

Claims (3)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】漢方薬の組合物であって、組み合わせが以
下の成分(重量分)である脳血管病救急治療薬。 牛黄(bezoar):5〜10分
麝香(musk):5〜15分 羚羊角(cornu satgae):20〜25分
氷片(boneol):20〜30分 郁金(curcuma root):20〜30分
乳香(boswellin):10〜15分 没薬(myrrh):10〜15分
芽皀(英語なし):15〜20分 陳皮(tangerine peel):15〜20分
琥珀(glessite):25〜30分
1. An emergency medicine for cerebrovascular disease, which is a combination of Chinese herbs, and the combination is the following components (by weight). Bezoar: 5-10 minutes
Musk: 5 to 15 minutes cornu satgae: 20 to 25 minutes
Boneol: 20-30 minutes Curcuma root: 20-30 minutes
Boswellin: 10 to 15 minutes Myrrh: 10 to 15 minutes
Sprout (no English): 15 to 20 minutes Tangerine peel: 15 to 20 minutes Amber (glossite): 25 to 30 minutes
【請求項2】形態が丸薬である請求1の治療薬。2. The therapeutic agent according to claim 1, which is in the form of pills. 【請求項3】請求項1記載の脳血管病が、脳血栓(ce
rebral infarction)、脳血栓形成
(cerebral thrombosis)、脳栓塞
(cerebral embolism)、脳出血(c
erebral hemorrhage)、蛛网膜下腔
出血(subarachnoid hemorrhag
e)等である救急治療及び予防薬。
3. The cerebrovascular disease according to claim 1, wherein the cerebrovascular disease is cerebral thrombosis (ce).
rebar infarction, cerebral thrombosis, cerebral embolism, cerebral hemorrhage (c)
erebral hemorrhage, subarachnoid hemorrhage
e) etc. Emergency treatment and preventive drugs.
JP2001235565A 2001-06-29 2001-06-29 “Shingu Fusaimaru”-Emergency middle-aged medicine (Chinese medicine) for treating cerebrovascular disease (CVD) Expired - Fee Related JP3479654B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001235565A JP3479654B2 (en) 2001-06-29 2001-06-29 “Shingu Fusaimaru”-Emergency middle-aged medicine (Chinese medicine) for treating cerebrovascular disease (CVD)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001235565A JP3479654B2 (en) 2001-06-29 2001-06-29 “Shingu Fusaimaru”-Emergency middle-aged medicine (Chinese medicine) for treating cerebrovascular disease (CVD)

Publications (2)

Publication Number Publication Date
JP2003034646A JP2003034646A (en) 2003-02-07
JP3479654B2 true JP3479654B2 (en) 2003-12-15

Family

ID=19066990

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001235565A Expired - Fee Related JP3479654B2 (en) 2001-06-29 2001-06-29 “Shingu Fusaimaru”-Emergency middle-aged medicine (Chinese medicine) for treating cerebrovascular disease (CVD)

Country Status (1)

Country Link
JP (1) JP3479654B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008075862A1 (en) * 2006-12-16 2008-06-26 Pusan National University Industry-University Cooperation Foundation A method for preparing materials having antithrombotic activity from muskrat musk and materials obtained from the method
CN104524426A (en) * 2014-12-05 2015-04-22 张洪胜 Traditional Chinese medicine for treating cerebral hemorrhage

Also Published As

Publication number Publication date
JP2003034646A (en) 2003-02-07

Similar Documents

Publication Publication Date Title
CN100536908C (en) Chinese medicinal herbs for treating spur and its preparation
CN1325083C (en) Medicinal composition for removing dampness to relieve itching and its preparation method and uses
CN100333762C (en) Externally used medicine for curing acute or chronic soft tissue injury and process for preparing the same
Melén et al. Effects of phenylpropanolamine on ostial and nasal patency in patients treated for chronic maxillary sinusitis
CN103099866A (en) Traditional Chinese medicine composition for treating anxiety and insomnia and preparation method thereof
WO2020135476A1 (en) Traditional chinese medicine composition, and preparation method therefor and application thereof
CN100389802C (en) Medicine for treating and preventing chronic obstractive pneumonia
JP3479654B2 (en) “Shingu Fusaimaru”-Emergency middle-aged medicine (Chinese medicine) for treating cerebrovascular disease (CVD)
CN100389780C (en) Traditional Chinese medicine for treating depressive disorders, and its prepn. method
CN107441265A (en) A kind of anti-inflammatory, repercussive and analgesic cream for being used to treat hemophiliac joints inflammation and hemotoncus
CN103961569A (en) Foot bath medicine bag
CN107080786A (en) Antidepressant compositions and its preparation method and application and medicine or pharmaceutical composition comprising it
CN101732424B (en) Chinese medicinal powder for treating pharyngitis
CN101406579B (en) Novel use of pinellia
CN101229193A (en) External Chinese patent medicine for treating skin ulceration and organism gangrene
Volden Peripheral neuropathy: a side effect of sulphones.
CN101357218B (en) Externally used medicine for treating diabetes and preparation method thereof
US3442899A (en) Treatment of arteriosclerotic and arteriospastic diseases with 1-(beta-hydroxyethyl) 2-methyl - 5 - nitroimidazole
CN111671852A (en) Plaster for treating hypertension
CN116889550A (en) Long-snake moxibustion powder for treating ankylosing spondylitis and preparation method thereof
Xu et al. Clinical Evaluation of the analgesic effect of sustained release morphine sulfate microgranules in patients with terminal cancer
CN100404051C (en) Chinese medicinal composition for treating coronary heart disease, stenocardia and its preparation method
CN1351870A (en) Blood circulation activating core
CN101926920A (en) Traditional Chinese medicine composition for treatment of rheumatoid arthritis and preparation method thereof
CN101164567A (en) Traditional Chinese medicine pillow pad for lowering blood pressure

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees